Acme United Stock Earnings Reports

Key points for investors: Acme United reported Q1 FY2026 net sales of $52.3M, up 14% year-over-year, but net income fell to $0.985M ($0.24 EPS) versus $1.6M ($0.41) a year ago (≈40% decline). The quarter includes the acquisition of My Medic (paid $18.6M), which contributed ~8% of the sales increase and was roughly breakeven on the P&L as the business invests in DTC advertising and customer acquisition. Reported gross margin was 39.7% (vs. 39.0% prior year) but core legacy margins declined—primarily due to elevated tariffs that were capitalized into inventory and recognized as higher cost of goods sold in Q1. Management expects the tariff impact to diminish over the next three quarters as tariff rates decline and older high-cost inventory is worked through. The company proactively purchased roughly $10M of incremental inventory after the Iran war began to hedge shortages/price increases. Med‑Nap (Brooksville) incurred about $1.25M of quality-assurance upgrades (consulting, lab/equipment) to meet higher hospital standards; roughly $300k was spent in Q1. SG&A rose to $19.0M (36% of sales) largely from My Medic advertising and integration costs; recurring SG&A run rate guidance implies a mid-30s percent of sales level (management indicated ~33% as a sustainable target excluding one-time items). Net debt increased to $38.6M (from $27.2M a year earlier) reflecting acquisitions, dividends, and facility purchases. Planned CapEx for FY2026 is roughly $6–7M for automation, new facility buildout, and capacity expansion (including the new Spill Magic facility in Mt. Pleasant, TN). Geographic performance: Europe up 19% (local currency) and Canada up mid-teens, aided by recent acquisitions (Schmiedeglut in Germany) and stronger first-aid sales. Strategic priorities: integrate My Medic to expand DTC capabilities and cross-sell, complete Med‑Nap QA upgrades, deploy automation to lower operating costs, and grow Spill Magic and cutting/sharpening segments. Key risks remain: tariffs, macro/ inflation/interest-rate environment, geopolitical disruptions, and supply-chain constraints.